Presentation to Highlight Single-Dose MVA and Continuous Cell-Line MVA Manufacturing Innovations. ATLANTA, GA - October 6, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), ...
HSINCHU, Dec. 2, 2025 /PRNewswire/ -- Amaran Biotech, a next-generation Contract Development and Manufacturing Organization (CDMO), announced that its self-developed, GMP-grade high-purity vaccine ...
Investor's Business Daily on MSN
Biotech stocks tumble, with recent winners Moderna, Vaxcyte among the biggest losers
Biotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses.
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...
Colombia’s €35 million EIB-backed VaxThera investment aims to strengthen domestic vaccine production, biotechnology research ...
Pre-clinical data for IO Biotech's next T-win vaccine candidate, IO112 targeting arginase 1, demonstrates anti-tumor activity with dynamic changes in the tumor microenvironment (TME) driven by the ...
Industry leaders and experts from across the globe will meet in Amsterdam to discuss advancements in research and development processes within the evolving vaccine industry. The event will address 12 ...
Vaxxinity Inc (ISIN: US92239B1035) develops innovative synthetic vaccine platforms targeting infectious diseases and oncology. North American investors should monitor clinical milestones and funding ...
Saudi Arabia's National Biotechnology Strategy combines infrastructure, talent, and strategic funding to transform the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results